BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Business Intelligence
Back to Companies Directory

Pathos

Pathos logo

Website
https://pathos.com/
Founded
2021

Technologies

AI Companies (Drug Discovery)

USA-based startup Pathos develops a platform that utilizes vast oncology data, genomic information, and advanced AI with laboratory environments to re-engineer drug development. The PathOS platform integrates real-world oncology data, patient-derived functional genomic data, and silicon analyses with biological modeling to design optimal clinical trials.


Articles Mentioning This Company

Companies Applying AI to De-Risk Clinical Trials: 2026 Watchlist

Companies Applying AI to De-Risk Clinical Trials: 2026 Watchlist

Nov. 10, 2026     Business Intelligence
Clinical development is still shaped by a stubborn asymmetry: only around one in ten drug candidates that enter human testing ever reaches approval, and Phase II/III failures remain the biggest drivers of wasted R&D spend. Despite growing use of de-risking strategies such as genetics-anchored target selection, increasing use of biomarker-stratified …

R&D Platform

The startup’s clinical development suite also harmonizes data from multiple sources, enabling a generalizable machine-learning framework for asset-specific analytics and AI models. Furthermore, Pathos’ Discovery Engine automates target identification and prioritization, refining targets using advanced AI and vast patient data, accelerating the development of precision medicines.

News

  • 2025-04-28
    Tempus Introduces Loop, an AI-Driven Platform for Target Discovery and Validation
  • 2024-08-16
    Pathos AI Acquires Brain-Penetrant PRMT5 Inhibitor for Precision Cancer Therapy

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.

Sign in or create an account